Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Development of CancerLinQ, a Health Information Learning Platform From Multiple Electronic Health Record Systems to Support Improved Quality of Care

Development of CancerLinQ, a Health Information Learning Platform From Multiple Electronic Health... PURPOSE: ASCO, through its wholly owned subsidiary, CancerLinQ LLC, developed CancerLinQ, a learning health system for oncology. A learning health system is important for oncology patients because less than 5% of patients with cancer enroll in clinical trials, leaving evidence gaps for patient populations not enrolled in trials. In addition, clinical trial populations often differ from the overall cancer population with respect to age, race, performance status, and other clinical parameters. MATERIALS AND METHODS: Working with subscribing practices, CancerLinQ accepts data from electronic health records and transforms the local representation of a patient's care into a standardized representation on the basis of the Quality Data Model from the National Quality Forum. CancerLinQ provides this information back to the subscribing practice through a series of tools that support quality improvement. CancerLinQ also creates de-identified data sets for secondary research use. RESULTS: As of March 2020, CancerLinQ includes data from 63 organizations across the United States that use nine different electronic health records. The database includes 1,426,015 patients with a primary cancer diagnosis, of which 238,680 have had additional information abstracted from unstructured content. CONCLUSION: As CancerLinQ continues to onboard subscribing practices, the breadth of potential applications for a learning health care system widen. Future practice-facing tools could include real-world data visualization, recommendations for treatment of patients with actionable genetic variations, and identification of patients who may be eligible for clinical trials. Feeding these insights back into oncology practice ensures that we learn how to treat patients with cancer not just on the basis of the selective experience of the 5% that enroll in clinical trials, but from the real-world experience of the entire spectrum of patients with cancer in the United States. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JCO Clinical Cancer Informatics Wolters Kluwer Health

Development of CancerLinQ, a Health Information Learning Platform From Multiple Electronic Health Record Systems to Support Improved Quality of Care

Download PDF
9 pages

Loading next page...
 
/lp/wolters-kluwer-health/development-of-cancerlinq-a-health-information-learning-platform-from-OhLSNzxt50
Publisher
Wolters Kluwer Health
Copyright
(C) 2020 American Society of Clinical Oncology
ISSN
2473-4276
DOI
10.1200/CCI.20.00064
Publisher site
See Article on Publisher Site

Abstract

PURPOSE: ASCO, through its wholly owned subsidiary, CancerLinQ LLC, developed CancerLinQ, a learning health system for oncology. A learning health system is important for oncology patients because less than 5% of patients with cancer enroll in clinical trials, leaving evidence gaps for patient populations not enrolled in trials. In addition, clinical trial populations often differ from the overall cancer population with respect to age, race, performance status, and other clinical parameters. MATERIALS AND METHODS: Working with subscribing practices, CancerLinQ accepts data from electronic health records and transforms the local representation of a patient's care into a standardized representation on the basis of the Quality Data Model from the National Quality Forum. CancerLinQ provides this information back to the subscribing practice through a series of tools that support quality improvement. CancerLinQ also creates de-identified data sets for secondary research use. RESULTS: As of March 2020, CancerLinQ includes data from 63 organizations across the United States that use nine different electronic health records. The database includes 1,426,015 patients with a primary cancer diagnosis, of which 238,680 have had additional information abstracted from unstructured content. CONCLUSION: As CancerLinQ continues to onboard subscribing practices, the breadth of potential applications for a learning health care system widen. Future practice-facing tools could include real-world data visualization, recommendations for treatment of patients with actionable genetic variations, and identification of patients who may be eligible for clinical trials. Feeding these insights back into oncology practice ensures that we learn how to treat patients with cancer not just on the basis of the selective experience of the 5% that enroll in clinical trials, but from the real-world experience of the entire spectrum of patients with cancer in the United States.

Journal

JCO Clinical Cancer Informatics – Wolters Kluwer Health

Published: Oct 26, 2020

References

  • 111th US Congress
    111th US Congress
  • Health IT
    Health IT
  • Institute of Medicine
    Institute of Medicine
  • The role of clinical trial participation in cancer research: Barriers, evidence, and strategies
    Unger JM; Cook E; Tai E
  • Off-label drug use in oncology: A systematic review of literature
    Saiyed MM; Ong PS; Chew L
  • Using oncology real-world evidence for quality improvement and discovery: The case for ASCO's CancerLinQ
    Miller RS; Wong JL
  • United States Department of Health and Human Services
    United States Department of Health and Human Services
  • US Government
    US Government
  • American Society of Clinical Oncology
    American Society of Clinical Oncology
  • Building a rapid learning health care system for oncology: The regulatory framework of CancerLinQ
    Schilsky RL; Michels DL; Kearbey AH
  • Office of the National Coordinator for Health IT
    Office of the National Coordinator for Health IT
  • Regenstrief Institute
    Regenstrief Institute
  • Normalized names for clinical drugs: RxNorm at 6 years
    Nelson SJ; Zeng K; Kilbourne J
  • National Library of Medicine
    National Library of Medicine
  • World Health Organization
    World Health Organization
  • National Cancer Institute
    National Cancer Institute
  • The state of oncology practice in America, 2018: Results of the ASCO Practice Census Survey
    Kirkwood MK; Hanley A; Bruinooge SS
  • Next-generation sequencing and the clinical oncology workflow: Data challenges, proposed solutions, and a call to action
    Conway JR; Warner JL; Rubinstein WS
  • American Society of Clinical Oncology
    American Society of Clinical Oncology
  • Health Level 7
    Health Level 7
  • CancerLinQ: Cutting the Gordian knot of interoperability
    Rubinstein WS